Berlin, Germany - Reviewing the clinical data on rituximab in rheumatoid arthritis (RA) during an oral presentation at last week's EULAR 2004 meeting, Prof Jonathan Edwards (University College, London ...

Anti-CD20 B cell-depleting agents such as rituximab may offer a promising initial disease-modifying treatment (DMT) for relapsing-remitting multiple sclerosis (RRMS) and primary progressive multiple ...

Rituxan (rituximab) may be prescribed for moderate to severe rheumatoid arthritis if TNF blocking agents haven’t worked, often with methotrexate. Administered intravenously in two infusions separated ...

Rituximab is the first monoclonal antibody to have been registered for the treatment of B-cell lymphomas. Randomized studies haves demonstrated its activity in follicular lymphoma (FL), mantle cell ...

Please provide your email address to receive an email when new articles are posted on . Learning from 2 decades of off-label rituximab use in systemic lupus erythematosus may point the way toward ...